FDG-PET shows significantly reduced uptake in the visual cortex in DLB patients [45]. Assessing dopaminergic function carries value in DLB, which can be done by dopaminergic transporter (DAT) scan by SPECT using (123I) FP-CIT as a radiotracer. This evidence concerns the gene SLC6A3 and Lewy body dementia.